Evelo Biosciences, Inc. Banner Image

Evelo Biosciences, Inc.

  • Ticker EVLO
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Evelo Biosciences, Inc. Logo Image
  • 51-200 Employees
  • Based in Cambridge, Massachusetts
Evelo Biosciences is a clinical stage biotechnology company developing oral biologics that act on SINTAX™, the small intestinal axis, with systemic therapeutic effects. SINTAX plays a central role in governing the immune, metabolic and neurological systems. The company’s first product candidates are pharmaceutical preparations of single strains of microbes selected for defined pharmacologicalMore properties. Evelo’s therapies have the potential to be effective, safe, and affordable medicines to improve the lives of people with inflammatory diseases and cancer.
4.8 / 5.0 (133)

Evelo Biosciences, Inc. reports have an aggregate usefulness score of 4.8 based on 133 reviews.

Evelo Biosciences, Inc.

Most Recent Annual Report

Evelo Biosciences, Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Evelo Biosciences, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!